drugset / Trial / NCT01002573

Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

NCT01002573 ↗

Phase 3 Completed 118 enrolled Cumberland Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of the study is to determine the superiority of a single dose of intravenous ibuprofen compared to acetaminophen for the treatment of fever during the first two hours of treatment.

Timeline

Start
2010-07
Primary completion
2013-06
Completion
2013-06

Outcome

Met primary endpoint

paper Intravenous ibuprofen resulted in a greater reduction in temperature as measured by the area under the change from baseline at 2 h (p = 0.005) PMID 28143430 ↗

paper provided a significant reduction of temperature for febrile pediatric patients compared to those that received 10 mg/kg acetaminophen at 2 h and 4 h post-treatment. PMID 28143430 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 10 mg/kg Oral
Subject Ibuprofen Small molecule 10 mg/kg Intravenous

Indications

No indication recorded.